Syphilis management for tertiary stage

Revision as of 02:50, 22 September 2017 by Mmir (talk | contribs) (Category)
Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Syphilis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Syphilis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary and Secondary Syphilis
Latent Syphilis
Tertiary Syphilis
Neurosyphilis
HIV-Infected Patients
Pregnancy
Management of Sexual Partners

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Syphilis management for tertiary stage On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Syphilis management for tertiary stage

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Syphilis management for tertiary stage

CDC on Syphilis management for tertiary stage

Syphilis management for tertiary stage in the news

Blogs on Syphilis management for tertiary stage

Directions to Hospitals Treating Syphilis

Risk calculators and risk factors for Syphilis management for tertiary stage

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]Aysha Anwar, M.B.B.S[3]; Nate Michalak, B.A.

Overview

Tertiary syphilis refers to gumma and cardiovascular syphilis but not to all neurosyphilis. Patients who are not allergic to penicillin and have no evidence of neurosyphilis should be treated with Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM each at 1-week intervals.

Management for Tertiary Stage Syphilis

CDC Recommendations: Pharmacotherapy

Recommended Regimen

Other Management Considerations

Patients who have symptomatic late syphilis should be given a CSF examination before therapy is initiated. Patients with cardiovascular syphilis may be treated with the same regimen as neurosyphilis but there is limited data available to support this.[3]

Special Considerations

Penicillin Allergy: Alternative Regimen

  • Patients allergic to penicillin should consult with an infectious disease specialist to determine an effective regimen.

Pregnancy

Follow-Up

  • Limited information is available concerning clinical response and follow-up of patients who have tertiary syphilis.

References

  1. "Sexually Transmitted Diseases Treatment Guidelines, 2010". Retrieved 2012-12-19.
  2. http://www.cdc.gov/std/tg2015/syphilis.htm#Neurosyphilis Accessed on September 27, 2016
  3. Carrada-Bravo T (2006). "[Cardiovascular syphilis: diagnosis, treatment]". Arch Cardiol Mex. 76 Suppl 4: S189–96. PMID 17469346.


Template:WikiDoc Sources